Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,604.50
Bid: 1,604.00
Ask: 1,604.50
Change: -5.50 (-0.34%)
Spread: 0.50 (0.031%)
Open: 1,611.50
High: 1,615.50
Low: 1,599.50
Prev. Close: 1,610.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Energy stocks lift UK's FTSE 100, Vodafone shines

Mon, 18th Dec 2023 17:21

Vodafone jumps as Iliad offers to merge Italian units

*

Entain gains on Jefferies upgrade

*

FTSE 100 up 0.5%, FTSE 250 adds 0.1%

Dec 18 (Reuters) - Britain's FTSE 100 climbed on Monday as heavyweight energy stocks rose, tracking strength in crude oil prices, while Vodafone's shares topped the list of gainers after telecom firm Iliad submitted a proposal to create a joint venture in Italy.

The blue-chip FTSE 100 gained 0.5%, while the more domestically focused FTSE 250 mid-cap index edged 0.1% higher.

Vodafone jumped 3.9% after Iliad said it submitted a proposal to the telecom company to merge their Italian businesses.

Heavyweight energy stocks added 1.5%, tracking a jump in crude oil prices, as mounting attacks by the Iran-aligned Yemeni Houthi militant group on ships in the Red Sea disrupted maritime trade.

"Given the importance of the Red Sea and Suez Canal as a crucial transit point for both crude oil and natural gas these suspensions mean that cargos face a lengthy diversion around the Horn of Africa which will add significant costs to company supply chains," said Michael Hewson, chief market analyst at CMC Markets UK.

Looking ahead, data due this week includes domestic and euro zone inflation, along with GDP estimates from Britain and the U.S.

The FTSE 100 is extending three consecutive weeks of gains on the back of hopes that the U.S. Federal Reserve could consider cutting interest rates soon.

Tempering some of those expectations, Atlanta Fed President Raphael Bostic pushed back on Friday saying the U.S. central bank can begin reducing rates "sometime in the third quarter" of 2024 if inflation falls as expected. New York Fed President John Williams has also sought to cool rate-cut forecasts.

Among other individual stocks, GSK gained 1.6% after the drugmaker said its cancer drug combination met its primary goal in a late-stage trial.

Entain advanced 4.1% after Jefferies upgraded the sports betting firm's rating to "buy" from "hold".

On the downside, Fresnillo lost 5.2% after Morgan Stanley downgraded its rating to "underweight" from "equal-weight". (Reporting by Shashwat Chauhan and Shubham Batra in Bengaluru; Editing by Sonia Cheema and Janane Venkatraman)

More News
11 Jun 2024 14:31

Zantac litigation fears overdone at GSK, says Shore Capital

(Sharecast News) - Volatile moves in GSK's share price are likely to persist in the near term as a result of ongoing Zantac-related litigation, but the long-term investment case is "still appealing", according to Shore Capital, which kept a 'buy' rating on the stock.

Read more
11 Jun 2024 09:32

TOP NEWS: GSK takes first steps to appeal Zantac ruling in Delaware

(Alliance News) - GSK PLC on Tuesday said it has taken the first steps to seek appeal of a ruling by the Delaware Superior Court in regard to its discontinued heartburn drug Zantac.

Read more
11 Jun 2024 09:12

LONDON MARKET OPEN: FTSE 100 up; UK unemployment rises to 4.4%

(Alliance News) - Stock prices in London opened higher on Tuesday, after a difficult day for markets on Monday amid the EU election fallout.

Read more
11 Jun 2024 07:52

LONDON BRIEFING: FTSE 100 called up despite unemployment rise

(Alliance News) - The FTSE 100 in London was called to open higher on Tuesday, after data showed that unemployment in the UK unexpectedly rose.

Read more
11 Jun 2024 07:22

GSK launches appeal to recent Zantac ruling

(Sharecast News) - GSK has started the process of appealing a recent decision by the Delaware Superior Court regarding the ongoing Zantac, or ranitidine, litigation, it announced on Tuesday.

Read more
11 Jun 2024 00:32

GSK asks to appeal Delaware ruling allowing Zantac cases to go forward

June 10 (Reuters) -

Read more
10 Jun 2024 22:49

Latest trial over Zantac cancer claims called off as plaintiff drops case

June 10 (Reuters) - A woman who claimed in a lawsuit that GSK's discontinued heartburn drug Zantac caused her breast cancer dropped her case shortly before it was set to go to trial in Illinois state court on Monday, the company announced.

Read more
10 Jun 2024 19:00

TOP NEWS: GSK welcomes dismissal of Zantac case in Illinois

(Alliance News) - GSK PLC on Monday welcomed the dismissal of a case in the US concerning the heartburn drug, Zantac, which was due to start on Monday.

Read more
10 Jun 2024 12:42

EU to secure 40 million avian flu vaccines for 15 countries - officials

BRUSSELS, June 10 (Reuters) - The EU will sign a contract on Tuesday to secure over 40 million doses of a preventative avian flu vaccine for 15 countries with the first shipments heading to Finland, EU officials said on Monday.

Read more
10 Jun 2024 08:39

GSK gets FDA approval for Arexvy vax in 50-59 year olds at risk of RSV

(Alliance News) - GSK PLC on Monday announced that the US Food & Drug Administration has approved an expanded age indication for its respiratory syncytial virus vaccine.

Read more
10 Jun 2024 07:37

LONDON BRIEFING: FTSE called down amid political uncertainty in EU

(Alliance News) - Stocks in London are called to open lower on Monday, setting off the week on the backfoot, with eyes on the US Federal Reserve's latest interest rate decision.

Read more
10 Jun 2024 07:17

GSK's Arexvy vaccine approved for wider age range

(Sharecast News) - US regulators have approved the use of GSK's Arexvy vaccine for a younger age group, the biopharma group announced on Monday.

Read more
7 Jun 2024 19:34

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, June 7 (Reuters) - The outbreak of bird flu in U.S. dairy cows has now been confirmed in Minnesota and Iowa, bringing to 11 the total number of affected states, which have been encouraged to ramp up testing efforts at the request of government officials.

Read more
5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
3 Jun 2024 17:20

European shares kick-off June on a high note in anticipation of ECB rate cut

GSK tumbles as Zantac lawsuits allowed to proceed

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.